353
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles

, , , , , , & show all
Pages 785-793 | Received 13 Jan 2022, Accepted 29 Aug 2022, Published online: 07 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianwen Zhou, Yao Tong, Wenquan Zhu, Xiaoyu Sui, Xiaoxing Ma & Cuiyan Han. (2023) Combination immunotherapy of PEG-modified preladenant thermosensitive liposomes and PD-1 inhibitor effectively enhances the anti-tumor immune response and therapeutic effects. Pharmaceutical Development and Technology 28:6, pages 501-508.
Read now

Articles from other publishers (3)

Fariba Farajizadeh, Farzaneh Taghian, Khosro Jalali Dehkordi & Rezvan Mirsafaei Rizi. (2023) Swimming training and herbal nanoformulations as natural remedies to improve sensory-motor impairment in rat midbrain tumor models: system biology, behavioral test, and experimental validation. 3 Biotech 13:5.
Crossref
Daoyuan Chen, Xuecun Liu, Xiaoyan Lu & Jingwei Tian. (2023) Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Frontiers in Pharmacology 14.
Crossref
Jun Zhang, Yanran Huang, Jingtao Xu, Runhan Zhao, Chuang Xiong, Jiwa Habu, Yuping Wang & Xiaoji Luo. (2022) Global publication trends and research hotspots of curcumin application in tumor: A 20-year bibliometric approach. Frontiers in Oncology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.